Cargando…
Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study
BACKGROUND: Vagal nerve blockade (vBloc) therapy was shown to be a safe and effective treatment for moderate to severe obesity. This report summarizes the safety and efficacy of vBloc therapy in the prespecified subgroup of patients with moderate obesity. METHODS: The ReCharge Trial is a double-blin...
Autores principales: | Morton, John M., Shah, Sajani N., Wolfe, Bruce M., Apovian, Caroline M., Miller, Christopher J., Tweden, Katherine S., Billington, Charles J., Shikora, Scott A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831996/ https://www.ncbi.nlm.nih.gov/pubmed/27048437 http://dx.doi.org/10.1007/s11695-016-2143-y |
Ejemplares similares
-
Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial
por: Apovian, Caroline M., et al.
Publicado: (2016) -
Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial
por: Shikora, Scott A., et al.
Publicado: (2015) -
Vagal Blocking Improves Glycemic Control and Elevated Blood Pressure in Obese Subjects with Type 2 Diabetes Mellitus
por: Shikora, S., et al.
Publicado: (2013) -
Methodology and Results of a Joint IFSO-WGO Delphi Survey of 94 Intercontinental, Interdisciplinary Experts in Obesity Management
por: Kow, Lilian, et al.
Publicado: (2023) -
Vagal plasticity the key to obesity
por: de Lartigue, Guillaume, et al.
Publicado: (2014)